The polyphenolic flavonoid Rutin possesses multiple therapeutic effects out of which the anti-inflammatory potential has been well established in the recent literatures. The oral bioavailability of Rutin is very low necessitating its novel drug delivery approach. Phyto-phospholipid complex (phytosomes) is helpful in enhancing oral bioavailability and transdermal permeation of polyphenols. In the present work, Rutin phytosomes (RN-P) were developed and characterized to establish its feasibility for transdermal application in inflammatory conditions. Phytosomes were prepared in five molar ratios of Rutin (0.5 -1.0) to Phosphatidylcholine (1.0 -0.5). All RN-Ps showed aqueous solubility higher than pure Rutin. Partition coefficient results indicated the lipophilic nature of free Rutin as well as all RN-Ps with most satisfactory value found at 3.11 ± 0.08 with F3 formulation. Discrete vesicular structures of RN-Ps observed in TEM study. Results of the FT-IR, DSC and XRD studies confirmed the phyto-phospholipid complex formation. XRD reports revealed the reduction in crystallinity of Rutin when in phytosomes form with F3 found to be the least crystalline. SEM studies confirmed the disappearance of rod shaped crystals of Rutin in phytosome formulations. The ex vivo skin permeation study across excised rat abdominal skin confirmed the higher permeability of RN-Ps (33 ± 1.33 %) over pure Rutin (13 ± 0.87 %). The observations made in the present work suggest that phyto-phospholipid complex of Rutin can increase its skin uptake to treat inflammatory conditions in arthritis, rheumatism, athletic aches and may able to deliver the drug for a long duration avoiding the problems associated with oral administration.
INTRODUCTION

Rutin
(3,3´,4´,5,7-pentahydroflavone-3-rhamnoglucoside) is one of the most common flavonoid constituents of many plants, e.g., Ruta graveolens of Marantaceae family (Kostova et al., 1999; Abdullah et al., 2008) or Sophora japonica (Kim and Yun-Choi, 2008) . It possesses antioxidant, anti-inflammatory, antithrombotic, antineoplastic, inhibits ultraviolet radiation-induced cutaneous oxidative stress and inflammation (Saja et al., 1998; Ropke et al., 2002; Casagrande et al., 2007) , chemopreventive (Hirose et al., 1999) , protective role in liver disease, cataract, and cardiovascular disease (Prabathianana et al., 2010) . It is also used to treat capillary fragility and hypertension (Yildzogle-Ari et al., 1991) , lowers hepatic as well as blood cholesterol and having antiplatelet activity (Park et al., 2002) . Among all beneficial effects, .
. the anti-inflammatory activityof Rutin was being well established in the world literature (Selloum et al., 2003; Obied et al., 2005; Wonhwa et al., 2012; Zeilhofer, 2006; Karki et al., 2013; Bouriche, 2005) and found its application in the treatment of inflammatory conditions associated with excessive leukotriene production, such as rheumatoid arthritis and inflammatory bowel disease (Appleton 2010) . However the use of Rutin is relatively limited due to its low water solubility (Pedriali, 2008) and poor bioavailability (Hollman, 1997) .
In recent years many novel drug delivery systems were being developed to overcome such drawbacks of Rutin. The 2-hydroxypropyl beta cyclodextrine inclusion complex of Rutin was found to possess higher solubility, stability, dissolution rate and oral bioavailability in dog (Miyakeet et al., 2000) . Rabiskova et al., 2012 developed coated chitosan pellets of Rutin for the treatment of inflammatory bowel disease. Rutinphospholipid complexes when tested for physicochemical properties and in vitro antioxidant activity, the results proved better efficiency in the form of complexes as compared to the pure molecules itself . (Jain et al., 2012) . Singh et al., 2012 reported that the Rutinphospholipid complex may be considered as a promising drug delivery system for improving the overall oral absorption and bioavailability of Rutin. Laxmi and Narendra 2012 prepared polymeric nanoparticles of Rutin and reported that Rutin in colloidal carrier enhanced the drug penetration into the skin, and because of its lipoidal nature, the penetrated drug concentrates in the skin and remains localized for a longer period of time, thus enabling drug targeting to the skin. In vitro skin permeation studies on a pig ear model demonstrated that Rutin ethosome formulations were better able to permeate compared to pure Rutin (Dhiman and Singh, 2013) . developed liposomein-hydrogel complex system of Rutin to enhance transdermal permeation. The objective of the present study was to formulate phyto-phospholipid complexes (phytosomes) of Rutin and to evaluate the feasibility for its potential transdermal application in inflammatory conditions for sustained therapeutic benefits.
MATERIALS AND METHODS
Materials
Rutin was purchased from TCI Chemicals (India) Pvt. Ltd., Chennai. Phosphatidylcholine (PC) (Egg lecithin) was purchased from Sigma Aldrich, Bangaluru.
Preparation of rutin phytosomes (RN-Ps)
Phytosomes were prepared by refluxing followed by solvent evaporation (Kidd and Head, 2005; Maiti et al., 2007 and Jiang et al., 2001) . RN-Ps was prepared in different ratios of Rutin to phosphatidylcholine as shown in Table1. Rutin (RN) was dissolved in methanol in a 200 ml beaker. In a 500 ml round bottomed flux phosphatidylcholine (PC) was dissolved in dichloromethane and Rutin solution was mixed. The mixture was refluxed for 3 hours at 70 °C. After 3 hours the mixture was cooled and then poured to petridish. The dish was kept open overnight at room temperature for evaporation of solvent. Then the product was kept in hot air oven at 60 °C for 2 hours. The dried product was stored in desiccators for further use.
Physicochemical evaluation of phytosomes
Solubility and partitioning
Solubility studies were performed by taking an excess of the sample in 5 ml of various solvent viz. water, phosphate buffer (pH 6.8), acetate buffer (pH 4.5). (Chaudhary and Sharma, 2007) . Partition coefficient was determined by shake flask method (Berthod, 2004) using different solvent systems (Table 2) .
Drug entrapment
A weighed quantity of phytosomes equivalent to 10 mg RN was added to 50 ml phosphate buffer pH 6.8 in a 100 ml beaker. The contents were stirred on a magnetic stirrer for 4 hours and then allowed to stand for one hour. Clear liquid was decanted and centrifuged (CF10 Centrifuge, Daihan Scientific Co. Ltd, Korea) at 5000 rpm for 15 minutes. After centrifugation the supernatant was filtered through 0.45  whatman filter paper and after suitable dilution absorbance was measured in UV at 257 nm (UV1800, Shimadju, Japan). The drug entrapment (%) was calculated using the following formula: Drug entrapment (%) = Actual amount determined/Theoretical amount present.
Particle size distribution
The prepared phytosome samples were dispersed in isopropyl alcohol by stirring on a magnetic stirrer for 10 minutes. The dispersion was analyzed in size analyzer (Malvern, Nano series, S90 Zetasizer).
X-Ray diffraction (XRD) study
XRD was done on pure Rutin and RN-Ps in different ratios of drug and PC to see the crystallinity in the substance. Sample was scanned in the angular range of 5 o -80 o in a PHILIPS XPert Pro X-Ray Diffractometer. Dried powder sample was kept in sample holder (20 mm × 15mm × 2mm) which was fitted into the instrument and X-ray was passed through the sample.
Differential scanning calorimetry (DSC)
DSC studies for pure rutin, phosphatidylcholine (PC), physical mixture of rutin and PC and phytosomes (1:1) were performed on a Perkin Elmer (USA) (Model JADE DSC) differential scanning calorimeter by heating samples over a temperature range of 50-300 o C in closed metal pans at the rate of 10 o C per minute under the environment of nitrogen gas.
Fourier Transform Infrared spectroscopy (FT-IR) Study
FT-IR studies were performed pure rutin, PC, physical mixture of RN and PC and phytosomes (1:1) were performed in an Alpha FT-IR spectrophotometer (Bruker, Germany). A small quantity of sample was placed just below the probe on to which the probe was tightly fixed and scanned in the wave number region 4000-500 cm -1 . The obtained IR spectra were interpreted for functional groups at their respective wave number (cm -1 ).
Scanning electron microscopy (SEM)
Drug and phytosomes samples were coated with gold in a Fine Coat Ion Sputter JFC-1100. Analysis was done on the coated sample by placing a pinch of sample in the JEOL (JSM 6360) Scanning electron microscope and surface morphology was viewed and photographed.
Transmission electron microscopy (TEM)
Sample was dispersed in water and a drop was placed on a carbon coated copper grid to form a thin film. The film was stained with 2% uranic acid and allowed to dry by air drying. The stained film was viewed and photographed in a JEOL (JEM 2100) transmission electron microscope.
Ex vivo skin permeation study
Skin permeation of selected phytosomes formulation (F3) was compared with skin permeation of free RN, as F3 was found . superior in terms of aqueous solubility, partition coefficient, crystallinity and drug entrapment than other RN-Ps (F1, F2, F4 and F5).
For the study, a modified Franz diffusion cell with a diffusional area of 1.766 cm 2 was used. Rat abdominal skin excised after sacrificing the animal was used in the study. Skin hairs were shaved and subcutaneous fats were removed carefully. Skin was mounted in the diffusion cell with the stratum corneum facing the donor compartment and the dermis facing the receptor compartment. To the donor compartment 10 mg Rutin or phytosomes equivalent to 10 mg Rutin was applied on the skin after dispersing in 0.5 ml water. The receptor compartment was filled with 32 ml phosphate buffer (pH 6.8) and maintained at 37 ± 0.5 o C under continuous stirring with a magnetic bar. From the receptor compartment 2 ml samples were withdrawn at predetermined time intervals up to 24 hours. Same volume of receptor compartment fluid was replaced after each sampling. Experiment was carried out in triplicate following the same procedure. Samples were analyzed in UV-Visible Spectrophotometer at 257 nm. The cumulative amount permeated at each time interval was calculated and a plot of cumulative amount permeated (Q, %) versus time (t, h) was constructed. The skin after 24 hours study was taken out of the diffusion assembly and was cut into small pieces and extracted with methanol by homogenizing in a tissue homogenizer. Aliquots of the extract were analyzed in the UV-Visible Spectrophotometer at 257 nm after suitable dilution with phosphate buffer (pH 6.8).
RESULTS AND DISCUSSION
Preparation of phytosomes
We prepared RN-Ps in five different ratios of drug to phosphatidylcholine. All formulations appeared pale yellow in color and were in lumps, i.e. not free flowing. Formulations with higher phospholipid content (0.5:1 and 0.75:1) found to be more viscous and sticky lumps. In phyto-phospholipid complex preparation obtaining a clear solution of drug and PC in the reaction solvent is a prerequisite. Dichloromethane was chosen for dissolving PC but rutin is insoluble in this mixture. Rutin is soluble in methanol. Dichloromethane and methanol are miscible with each other at any volume. Rutin and PC were dissolved separately in methanol and dichloromethane respectively and the two solutions were mixed and then refluxed (Table 1) .
Solubility and partitioning
Rutin as reported in many literatures (Miyake et al., 2000; Mauludin et al., 2009) found to be highly hydrophobic in nature with water solubility 0.0639 ± 0.008 mg/ml. While its aqueous solubility in basic pH is higher (0.426 ± 0.091 mg/ml) than in acidic pH (0.0551 ± 0.032 mg/ml). Rutin phytosomes were found to be better soluble than pure Rutin with the order of solubility in phosphate buffer pH 6.8 water acetate buffer pH 4.5 (Table2). The amount soluble in mg/ml significantly varied as the ratio of Rutin to phosphatidylcholine varied. Highest solubility was observed for F3 where the molar ratio of Rutin to Phosphatidylcholine is 1:1. Results show that F3 solubility in Table 2) . The reason may be attributed to higher quantity of Rutin that remained unbound where RN: PC ratios were 1:0.5 (F4) and 1:0.75 (F5). Partition coefficient can be considered as an important factor for predicting skin permeability from an aqueous environment to the lipophilic stratum corneum (Cal, 2006) . For transdermal absorption the permeant should possess (octanolwater) partition coefficient in the range -1.0 to 4.0 (Chandrasekhar and Shobharani, 2008; Panchagnula, 1997) The results of the partition coefficient study are presented in Table 2 . Partition coefficient values of pure RN were 7.04 ± 0.28 (ocanol/water), 6.36 ± 0.33 (octanol/Phosphte buffer pH 6.8) and 8.10 ± 0.44 (octanol/acetate buffer pH 4.5). The results indicate lipophilic nature of RN. Partition coefficient value when exceed 3 may retard drug absorption via skin due to difficulty in permeating the hydrophilic epidermis/dermis beneath the SC (Schneider et al., 2009; Hung et al., 2010) . Keeping this fact in mind the most satisfactory partition coefficient value for RN-P was exhibited by F3 (3.11 ± 0.08) taking phosphate buffer pH 6.8 as the aqueous medium. Aqueous solubility of drug as well as n-octanol/water partition coefficient are important factors in designing formulations for transdermal application and deciding the fate of permeant for transdermal absorption. However, skin permeation of drug not solely dependent on lipophilicity, but there may be multiple factors and the way the viable dermis respond to a particular permeant.
Drug entrapment
All phytosomes formulations contain near to 100 % of drug (Table 3) . The results indicate uniform binding of drug and phosphatidylcholine. In formulation F1 and F2 the relatively lower drug content (97.38 % and 95.22 %) may be due to the presence of unbound phosphatidylcholine where Rutin was in 0.5 and 0.75 fraction. In formulation F3, F4, and F5 molar content of RN was higher than phosphatidylcholine and that is why drug and PC obtained sufficient opportunity to interact with each other as PC provide more than one site for drug binding resulting in higher drug content of 99.62 % to 101.08%.
Particle size
Average particle size varied between 684 nm to 1628 nm (Table 3 ). The results indicate that as the molar fraction of RN increased in phytosomes from 0.5 (F1) to 2 (F5), the particle size gradually increased. The reason may be attributed to the availability of number of RN molecule as compared to phospholipid molecule in contact during complex formation.
X-Ray diffraction study
XRD of RN shows intense crystalline peaks (Figure 1 ), indicating higher crystallinity of the drug. Such peaks are relatively less intense in phytosome formulations. Among the phytosome formulations, F3 exhibited least number of crystalline peaks, and it was interpreted that F3 (phytosome 1:1) would be more amorphous than phytosomes prepared in other ratios of RN: PC, i.e. 0.5:1, 0.75:1, 1:0.75 and 1:0.5 
Scanning electron microscopy (SEM)
SEM photographs give important insight into the solid state properties and surface morphology of drug and drug complexes. The highly crystalline state of Rutin was visualized in the SEM photograph as numerous rod shaped crystals. Such crystalline structures were found in some complexes (F4, F5) but absent in the others (F1, F2, and F3 ). From these results it was assumed that phytosomes complex formation was incomplete in F4 (1:0.5) and F5 (1:0.75) and still drug exist in original rod shaped crystals. Whereas in formulation F1 (0.5:1), F2 (0.75:1) and F3 (1:1) drug completely converted to phytosomes where RN was physically enwrapped by PC imparting amorphous nature to the complexes due to which the rod shaped crystals disappeared.
FT-IR study
Rutin showed IR absorption (Figure 3 This eliminates the possibility of any incompatibility of these combinations. Further, it can also be read that RN-PC complexes (phytosomes) involve only weak physical bonding. These results are in good agreement with those of Freag et al., 2013 who reported that some weak physical interactions took place between diosmin (-OH) and the phospholipid phosphate group during complex formation. 
Differential scanning calorimetry (DSC)
DSC thermogram of PC shows endothermic peak at 150.4ºC, 172.7ºC and 180.8ºC. RN shows broad endothermic peak at 175.6ºC. The physical mixture of PC and RN shows endothermic peak at 149.57ºC and 174.89ºC, respectively, which are almost 1ºC lower than the single compounds. The peaks for PC at 172.7ºC and 180.8ºC were not detectable in the physical mixture. The DSC thermogram of phytosomes gives two endothermic peaks at 145.8 o C and 171.31 o C, which were at still lower temperature than the physical mixture; also the peaks for the single compounds PC and RN disappeared. For the complexes the phase transition temperature was lower than the phase transition temperature of PC. The thermogram suggests some kind of interaction between PC and RN. Such interaction according to Xu et al., 2009 results from combination of hydrogen bonds or van der Waals forces, but the interaction does not lead to the formation of new compound. After the combination of RN and the PC through weak bonding, the carbon-hydrogen chain in phosphatidylcholine could turn freely and enwrap the phospholipids molecule polarity parts to which drug is bonded, which made the sequence decrease between phospholipids aliphatic hydrocarbon chains, made the endothermic peak of phospholipids ( at 180.8ºC) disappear and depressed the phase transition temperature (Figure 4 ). 
Transmission electron microscopy (TEM)
TEM study reveals the formation of discrete vesicular structure which appeared as imperfect spheres ( Figure 5 ). When dispersed in water by slightly shaking, phytosomes arranged themselves in order as a response to surface tension. TEM photographsof RN-P depicts the established theory that phytosomes results from the effective physical enwrapment of the polyphenol by one or more PC molecules (Kidd, 2009) . 
Ex vivo skin permeation study
Skin uptake of RN-P was found to be greater than RN. At the end of 24 hours 13 ± 0.87 % of RN was released whereas a higher amount of RN (33 ± 1.33 %) was found in case of RN-P in the receptor fluid ( Figure 6 ). The results show higher permeability of RN-Ps, where phosphatidylcholine played a major role in bringing the RN molecules via the lipophilic stratum corneum to epidermal dermal site and passing the viable dermis which is hydrophilic in nature. RN as well as RN-P was lipophilic as discussed in partition coefficient results; do not find easy passage through the viable dermis, which may be the reason of lower cumulative (%) permeation after 24 hours. This increases the possibility of accumulation of RN either in free form or as complex at the epidermal dermal site beneath the stratum corneum, as it was reported in earlier works that phyto-phospholipid complexes enhance the passage through the outer lipophilic horney layers (Semalty et al., 2008; Chen et al., 2012) . The skin extract obtained from the skin used for permeation study of free RN revealed that it contains 17 ± 1.06 % RN. Whereas the skin extract obtained from permeation study using F3 showed 44 ± 1.52 % RN content. The results suggest that the RN phytosomes are better able to penetrate the highly impermeable stratum corneum than free RN. Retention of this higher quantity of RN will be available for slow passage through the viable dermis and prolonged anti-inflammatory effect at superficial as well as deep skin and adjacent muscular tissues and bone interlocks for getting relief in arthritis, rheumatism, athletic aches etc.
CONCLUSIONS
Phytosomes first developed and patented by the Italian firm Indena, after which many of the polyphenolic bioflavonoids were being made into phytosomes such as silybin, green tea polyphenols, grape seed proanthrocyanidin, curcumin, etc. Rutin has got serious oral bioavailability problem though it possess potent anti-inflamatory effect. Observations made in the present work suggest that the rutin phytosomes can increase the skin uptake of rutin to treat inflammation leading to pain and swelling either superficial or deep skin. Rutin phytosomes may able to deliver rutin for a long duration as supported by the results of 24 hours permeation study, for relief in arthritis, rheumatism, athletic aches. Further investigation is needed to develop transdermal patch incorporating the optimized phytosome suitable for application on the skin surface.
